Company Ventures
335 Madison Ave Fl 3, New York City, New York, 10017, United States
Overview
Company Ventures is an early-stage venture firm that facilitates interactions between peers and delivering a dynamic shared experience. The firm helps businesses of all sizes unlock true value. It was founded in 2018 and headquartered in New York, United States.
- Total investments
- 56
- Lead investments
- 0
- Investments · 12mo
- 8
- Active investors
- 3
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Boom
Participated · Series A · Aug 2026
Boom provides an AI-native leasing operating system that combines leasing operations, applicant screening, and rent reporting in one platform. The company launched BoomScreen in mid-2024 and has since introduced BoomCRM, an AI-powered leasing and touring CRM designed to manage the entire leasing funnel from lead capture to tour booking, screening and approval. Boom reports supporting 500K+ rental units and more than 500 operators on its platform, and says its tools reduce response times to seconds and decisions to hours. The product embeds modern large language models across workflows to automate and speed leasing tasks. Boom has attracted both institutional venture investors and strategic operator investors and recently closed a $15M Series A led by S3 Ventures. The company states strong customer momentum and adoption following its product launches.
- Claryx
Participated · Seed · Aug 2026
Claryx develops genomic surveillance technology—branded CloneLink—that reads genomes of confirmed patient infections, links related cases into outbreaks, and traces each to likely sources including environmental reservoirs. The platform also builds a digital twin of a hospital from air, water and surface sampling to locate reservoirs of transmission, and Claryx says its proprietary chemistry cuts the most expensive sequencing step by more than twentyfold so continuous running is affordable. The company was founded by Kurt and Dirk Hackenberger and is based in New York, and it is already live across multiple health systems. The team highlights peer-reviewed results from a two-year study at UPMC Presbyterian that found 172 otherwise undetected outbreaks, stopped 96% of traced outbreaks, and estimated avoided infections, deaths and a 3.2-fold return on the program cost. Claryx positions itself as building a "hospital immune system" that detects transmission in real time and confirms when interventions worked. The company announced a $3.5 million pre-seed raise to scale deployments and operations.
- Prosper AI
Participated · Series A · Jun 2026
Prosper AI operates an AI platform that automates the full patient journey — answering patient calls, scheduling appointments directly in electronic health records, verifying insurance benefits, automating patient billing, and contacting insurers when needed. The company reports it helps providers lower administrative costs by over 40% and gives patients visibility into coverage and financial responsibility before care. Since its last funding announcement six months ago, Prosper AI grew revenue fivefold, added more than 40 healthcare organizations as customers, and expanded across more than 150,000 healthcare providers. The platform now powers more than $1.3 billion in patient care. Prosper AI was founded in Spain and has seen rapid adoption from provider groups, health systems, and healthcare technology companies. The company plans to use new capital to grow engineering and customer teams, deepen EHR integrations, and accelerate broader adoption.
- Kubera Health
Participated · Seed · May 2026
Kubera Health provides an AI-native platform that converts a customer's payor-provider contracts, amendments, fee schedules, and policies into structured rules that run continuously against claims and payment data. Its product suite includes Contract Intelligence and a Contract Modeler for organizing documents, tracking deadlines, benchmarking terms, and modeling contractual changes against historical claims, plus Payment Auditing and Policy Intelligence to surface discrepancies and bring payor coverage rules into the same system. The company primarily targets mid-to-large health systems with complex managed care operations and says every customer to date has expanded their engagement, with Hollywood Presbyterian Medical Center cited as a user. Founder and CEO Roja Garimella launched the company from experience at Humana and Commonwealth Care Alliance. Following a $6.5 million seed round led by Upfront Ventures, Kubera plans to invest the proceeds in product, engineering, go-to-market, expanding into value-based care contract structures, and building a payment recovery layer.
- UnityAI
Participated · Series A · Mar 2026
Founded in 2023 by former HCA Healthcare executives, Nashville-based UnityAI develops artificial-intelligence scheduling agents that streamline operations for outpatient and specialty care providers. Its platform keeps clinical workflows moving in high-volume, rapidly changing environments, reducing administrative bottlenecks for customers such as Tennessee Oncology and Peregrine Health. The company reports that its solution is already deployed at nationwide scale, demonstrating reliable performance in real-world clinical settings. Proceeds from the latest round will be used to deepen product capabilities and expand go-to-market efforts, especially with multi-site provider platforms. UnityAI aims to move health systems beyond isolated point solutions toward integrated, AI-powered operations. Including the new capital, the startup has raised a total of $15 million to date, underscoring growing investor confidence in its approach.